Latest News and Press Releases

WINNIPEG, MANITOBA--(Marketwired - Dec. 21, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on December 21, 2016, it issued 251,385 common shares of the...

WINNIPEG, MANITOBA--(Marketwired - Dec. 16, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation" or "Kane Biotech") today announced that a special resolution of the shareholders...

WINNIPEG, MANITOBA--(Marketwired - Nov. 25, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation" or "Kane Biotech") today announced that the Corporation has sent a notice of...

WINNIPEG, MANITOBA--(Marketwired - Oct. 19, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") is pleased to announce the launch of new packaging and branding...

WINNIPEG, MANITOBA--(Marketwired - Sept. 28, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on September 28, 2016, it issued 256,600 common shares of the...

WINNIPEG, MANITOBA--(Marketwired - July 11, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation" or "Kane Biotech") today announced that the global animal health company with...

WINNIPEG, MANITOBA--(Marketwired - June 29, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation" or "Kane Biotech") today announced that the Corporation has closed its...

WINNIPEG, MANITOBA--(Marketwired - June 21, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - June 5, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...

WINNIPEG, MANITOBA--(Marketwired - June 2, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") today announced the intention of the Company to undertake a...